- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Insight buys 21 imaging centers
InSight Health has completed the purchase of 21 of 22 diagnostic imaging centers formerly owned by Cardinal Health and contracted for sale to the national provider of diagnostic imaging services. Cardinal Health announced plans to sell the imaging
InSight Health has completed the purchase of 21 of 22 diagnostic imaging centers formerly owned by Cardinal Health and contracted for sale to the national provider of diagnostic imaging services. Cardinal Health announced plans to sell the imaging centers to InSight shortly after acquiring them as part of its Jan. 1, 2003, purchase of Syncor International. Sale of the centers was expected to involve a series of transactions beginning about Jan. 31 and running until early May 2003 (SCAN 1/22/03). The first transaction, involving 13 imaging centers in Southern California, was completed in April 2003 in a deal valued at $47 million. The current deal involving 22 imaging centers in six states carries a $48.3 million price tag, including $35.6 million in cash and $12.7 million in debt assumption and transaction costs (SCAN 2/25/04). The two companies are still negotiating the sale of the 22nd center.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
